Drug-Related Deaths (DRDs) soon after release: I Effectiveness on Trial: II Naloxone (heroin antidote) on release to reduce overdose deaths - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

Drug-Related Deaths (DRDs) soon after release: I Effectiveness on Trial: II Naloxone (heroin antidote) on release to reduce overdose deaths

Description:

Title: Critical appraisal of UK s evidence-base on treatment drug-dependent offenders. Why Australia is a leap ahead . . . Author: Template – PowerPoint PPT presentation

Number of Views:341
Avg rating:3.0/5.0
Slides: 25
Provided by: temp154
Category:

less

Transcript and Presenter's Notes

Title: Drug-Related Deaths (DRDs) soon after release: I Effectiveness on Trial: II Naloxone (heroin antidote) on release to reduce overdose deaths


1
Drug-Related Deaths (DRDs) soon after release
IEffectiveness on Trial II Naloxone (heroin
antidote) on release to reduce overdose deaths
  • (sheila.bird_at_mrc-bsu.cam.ac.uk)

2
HMP Edinburgh
3
John Pearce, former governor of Edinburgh Prison,
1990
  • Dr. A. Graham Bird, clinical immunologist.

4
1991 WASH
  • Willing ethical
  • Anonymous
  • no deductive disclosure
  • Saliva linked self-Q high volunteer rate
  • HIV surveillance
  • Linked to self-Q on risks frank answers

5
(No Transcript)
6
1. Seaman, Brettle Gore BMJ (1998)
  • Overdose deaths in 2 weeks after HIV injectors
    releases from HMP Edinburgh 1983-94
  • 8 times higher than for comparable other
    fortnights at liberty (p lt 0.01)
  • 7 drug-related deaths, 6 from overdose.

7
2. Male index releases from Scottish prisons in
July to Dec. 1996-99 Bird Hutchinson
Addiction 2003
  • Eligibility set by BH
  • Applied by Scottish Prison Service SPS
  • male
  • born in 1960 aged 15-35 years on release
  • served 14 days in prison
  • 1st release in July-December
  • calendar years 1996 to 1999

8
Design assumptions
  • 20,000 eligible releases
  • 2. At least 40 adult 20 young offender male
    index releases injectors (IDUs)
  • 3. Drugs-Related Deaths (DRDs) mainly IDUs
  • In 1990s one DRD per 3000 recently released
    IDU-days (not 1 per 1000, as Seaman)
  • 5. Relative Risk 1st fortnight DRDs 4

9
Drugs-related deaths in fortnight after prison
19 486 male ex-prisoners, aged 15-35 years,
released after 14days incarceration
DEATHS 1st 2 weeks subsequent 5 fortnights RELATIVE RISK(95 CI)
Drugs-related 34 23 (11 in 2nd fortnight 12 in next 8 wks) 7 (3 to 16)
Other causes 3 18 0.8 (0.2 to 2.4)
10
1 in 200 adult injectors dead within 2 weeks
after prison
  • Judges
  • aware?

11
Internationally, 6 major studies
Merrall et al., 2010 Addiction Studies DRDs pys at risk DRD rate per 1 000 pys DRDs pys at risk DRD rate per 1 000 pys DRDs pys at risk DRD rate per 1 000 pys 1st fortnight Relative Risk (95 CI)
Merrall et al., 2010 Addiction Studies 1st fortnight 2nd fortnight next 8 weeks 1st fortnight Relative Risk (95 CI)
UK (EW Scotland) 92 2 588 36 20 2 547 8 42 10 795 4 7.5 (5.7 to 9.9)
Australia (NSW Western) 187 7 759 24 64 7 416 9 144 27 334 5 4.0 (3.4 to 4.8)
USA (Washington State New Mexico prisons) 27 1 466 18 8 462 17 5 1 426 4 3 462 6 10 5 409 2 10 1 845 5 8.4 (5.0 to 14.2) 3.1 (1.3 to 7.1)
12
Why prisoners outside implications?
  • Need
  • Research Efficiency
  • concentration of adult heroin injectors ( 40)
  • ii) at very high risk
  • iii) well-defined period soon after release
  • iv) Third to half injectors in prison in past
    year
  • v) proof-of-principle for other settings
  • 1 in 8 Scottish DRDs occurs in 4 weeks after
    release!

13
Prison-based interventions
  • Information leaflet how to avoid overdose risk
    after release
  • b) Naloxone on release heroin antidote

14
UKs Advisory Council on the Misuse of Drugs
already on the case in 2000 . . .
  • 2005
  • Naloxone was added to UKs exempt list of
  • Prescription Only Medicines
  • for administration by anyone
  • in an emergency to save life

15
N-ALIVE randomise 56,000 eligible prisoners in
50 UK prisons in 5 years
  • Good luck, Prof Bird . . .
  • Three musketeers (2008) John Strang, Max Parmar
    Sheila Bird

16
Design assumptions N-ALIVE
  • Eligibility 18-44 years, history of heroin
    injection,
  • 7 days incarceration.
  • 1. At 80 of overdoses, some-one else is present
  • 2. 75 chance ex-prisoner carries Naloxone in 1st
    4 weeks post-release 50 chance in next 8 weeks
  • 3. 50 chance that Naloxone is administered by
    present other.
  • Effectiveness in 1st 4 weeks 30
  • Effectiveness in weeks 5 to 12 20
  • 21st C One overdose death in 1st 4 weeks per 200
    ever-IDUs randomised to control group.
  • 5. Contamination . . .

17
Prison-based, with-consent RCT for 56,000
pre-release adult IDUs
Expected drugs deaths 1st 4 weeks after release Next 8 weeks after release
Controls 28,000 IDUs 140 35
Naloxone 28,000 IDUs 98 28
18
UK-affordable cost of Naloxone
  • If CE threshold is 20K (40K) per life year
    gained,
  • Naloxone prevents
  • 42 drug deaths in 1st2nd fortnight per 28,000
    IDU releases ?
  • Per injector-inmate, UKs NHS can afford to pay
  • 42 20K /28,000 30
  • for pre-release Naloxone

19
N-ALIVE designed to fit with UK prison routines .
. .Induction drug awareness N-ALIVE DVD 1-1
consent each randomized prisoner has an assigned
N-ALIVE pack.Assigned N-ALIVE packs held in
Pharmacy or Prisoners valuables.Prisoner
escort ? release from court . . .Date of release
is critical.N-ALIVE DVD copy for prisoners
family Re-randomization of recidivists . . .
?
20
N-ALIVE cleaves to prison routines
  • Prisoner-induction includes drugs awareness
    session N-ALIVE DVD added.
  • (educates peers/family re N-ALIVE Naloxone)
  • N-ALIVE addiction workers informed consent,
    randomisation, liaison with pharmacy Clinical
    Trials Unit re release dates.
  • (half-time is research activity)
  • N-ALIVE pack handled by pharmacy escort staff
    as a medicine that accompanies prisoner to court,
    on transfers.
  • (issued only on release)

21
Informed consent by prisoners
  • Treatments Naloxone or control pack at release
    information leaflet prepaid reply card
  • Confidential database linkage to deaths register
  • and NFO AE admissions in N-ALIVE PILOT RCT
  • Random assignment blinded until release
  • Follow-up of recidivists via brief self-Q (unique
    )
  • Single phone contact in 1st or 2nd fortnight
    after release (for HALF only of randomised
    participants in PILOT RCT only . . . Because
    phone-contact contaminates N-ALIVE intervention)

22
N-ALIVE Recidivist self-Q
  • RCT flag against prisoner number so that on
    re-incarceration applies to 60 of IDUs
  • IDU attends prison health to answer
  • no-names, selotape-seal, self-Q re
  • overdose(s) witnessed fatal/non,
  • overdose(s) experienced alone/accompanied
  • naloxone use/disposal/acquisition/where kept
  • heroin use.

23
(No Transcript)
24
Pilot N-ALIVE . . . kicking via
  • Medical Research Councils Clinical Trials Unit
    welcomes international collaborations
  • Scottish Prison Service
  • (Karen Norrie, Andrew Fraser Ruth Parker,
    Stephen Heller-Murphy governors, security HC)
  • Health Department/Prison Service in EW
  • (Dave Marteau, Martin Lee)
  • Prisoners in both services
Write a Comment
User Comments (0)
About PowerShow.com